CONTROLLED EQUITY OFFERING AGREEMENTControlled Equity Offering Agreement • December 30th, 2011 • Apricus Biosciences, Inc. • Pharmaceutical preparations • New York
Apricus Biosciences, Inc., a corporation organized under the laws of Nevada (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Manager”) as follows:
AURINIA PHARMACEUTICALS INC. (existing under the Business Corporations Act (Alberta)) Controlled Equity OfferingSMControlled Equity Offering Agreement • November 19th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Aurinia Pharmaceuticals Inc., a company existing under the Business Corporations Act (Alberta) (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
Oramed Pharmaceuticals Inc. Shares of Common Stock (par value $0.012 per share) Controlled Equity OfferingSMControlled Equity Offering Agreement • September 1st, 2021 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
APRICUS BIOSCIENCES, INC. CONTROLLED EQUITY OFFERING AMENDMENT NO. 1 TO CONTROLLED EQUITY OFFERING AGREEMENTControlled Equity Offering Agreement • May 10th, 2013 • Apricus Biosciences, Inc. • Pharmaceutical preparations • New York
